Munich - Delayed Quote EUR

Merck & Co Inc (6MK.MU)

91.10

0.00

(0.00%)

As of 8:08:05 AM GMT+1. Market Open.

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)

RAHWAY, N.J., January 27, 2025--FDA Accepts for Priority Review Merck's Application for WELIREG for Treatment of Advanced PPGL

Business Wire 2 hours ago

MRK
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim […]

Insider Monkey yesterday

MRK
Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now?

We recently published a list of 12 Best Dow Stocks to Buy Right Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best dow stocks to buy right now. The Dow Jones Industrial Average is among the most popular stock market indices globally. […]

Insider Monkey yesterday

MRK

^DJI
Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?

We recently compiled a list of the Billionaire Prem Watsa’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other long-term stock picks. Prem Watsa is a Canadian billionaire, entrepreneur, and investor often referred to as the Canadian Warren […]

Insider Monkey 3 days ago

MRK

FAXRF
Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma

RAHWAY, N.J. & NUTLEY, N.J., January 24, 2025--Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial

Business Wire 3 days ago

MRK
The total return for Merck (NYSE:MRK) investors has risen faster than earnings growth over the last three years

Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are...

Simply Wall St. 3 days ago

MRK
Why Is Merck & Co., Inc. (MRK) Among the Best Large-Cap Value Stocks to Buy in 2025?

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other large-cap value stocks. Why is this Portfolio Manager Cautiously Optimistic? The market outlook is as uncertain as it gets. […]

Insider Monkey 4 days ago

MRK
Here’s Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other high yield dividend stocks. Dow is one of the most well-known and influential stock market indices globally. It monitors the […]

Insider Monkey 4 days ago

MRK

^DJI
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

Investor's Business Daily 4 days ago

MRK

ORCL

MRNA
Is Merck & Co., Inc. (MRK) the Best Stock to Invest In For Steady Dividends?

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming for a while. Dan Lefkovitz, a strategist at Morningstar […]

Insider Monkey 4 days ago

MRK
Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others

Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM (QCOM), as well as two micro-cap stocks CSP Inc. (CSPI) and AMCON Distributing Company (DIT).

Zacks 6 days ago

CVX

MRK

QCOM
Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. WEC Energy, Fifth Third Bancorp and Merck have rewarded shareholders for years and recently announced dividend increases. ...

Benzinga 6 days ago

WEC

FITB

MRK
Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $97.92 as of Jan 17th. MRK’s trailing and forward P/E were 20.49 and 10.15 respectively according to Yahoo […]

Insider Monkey 7 days ago

MRK
Trending tickers: Trump Media, Intel, Alibaba, Novo Nordisk and Entain

The latest investor updates on stocks that are trending on Monday.

Yahoo Finance UK 7 days ago

TCEHY

TCTZF

LVMHF
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks on Jim Cramer’s radar. Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus […]

Insider Monkey 7 days ago

MRK
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025?

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best cheap stocks to buy for 2025. The U.S. consumer prices report released this week revealed a less-than-expected increase in December, […]

Insider Monkey 8 days ago

MRK
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Trump's second term is bringing back some concerns from his first term, adding pressure to the health sector.

Yahoo Finance 8 days ago

AZN

AZNCF

MRK
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027, the agency said in a statement. The selected drug list for the second cycle of negotiations is: Novo Nordi

TipRanks 9 days ago

NONOF

NVO

BMY
Medicare to negotiate prices on 15 drugs, including Ozempic

Medicare seeks to negotiate prices on 15 drugs, including Novo Nordisk's (NVO) GLP-1 weight-loss drugs Ozempic and Wegovy, in new talks. Yahoo Finance senior health reporter Anjalee Khemlani explains the process and the range of other drugs on this new list from pharmaceutical giants Pfizer (PFE), AstraZeneca (AZN), Merck (MRK) To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 9 days ago

PFE

MRK

AZN
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Yahoo Finance 9 days ago

AZN

AZNCF

TEVA

Performance Overview

Return	6MK.MU	S&P 500
YTD	-4.21%	+1.52%
1-Year	-15.05%	+22.61%
3-Year	+42.53%	+37.86%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merck & Co Inc (6MK.MU)

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)

Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now?

Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma

The total return for Merck (NYSE:MRK) investors has risen faster than earnings growth over the last three years

Why Is Merck & Co., Inc. (MRK) Among the Best Large-Cap Value Stocks to Buy in 2025?

Here’s Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow

Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines

Is Merck & Co., Inc. (MRK) the Best Stock to Invest In For Steady Dividends?

Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others

Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income

Merck & Co., Inc. (MRK): A Bull Case Theory

Trending tickers: Trump Media, Intel, Alibaba, Novo Nordisk and Entain

Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’

Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025?

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Medicare to negotiate prices on 15 drugs, including Ozempic

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Performance Overview